The main play is obvious which is to make this as enticing as possible for a takeover.
Last year Otto Buttula retired from the board as late as the AGM , or such a mutually agreed , earlier time . Once either board renewal and an adequate handover , or a potential take over can be completed . The company remains in discussions with it advisors regarding attracting a new cornerstone shareholder , or full takeover.
Brian Leedman also retired from the board last year . He was a co- founder of Resapp ( RAP ) and did say they would never make any money but would still be acquired ( taken over ) which it was. The current Oncosil leadership team still consist of expertise from Sirtex which was taken over for $1.9 billion and Telix Pharmaceuticals TLX , around a $ 7 billion market cap. Brian Leedman has also mentioned that , You can only have a blockbuster product if a big pharma is selling it and mentioned Sirtex as a comparison and that is the ultimate outcome for Oncosil.
The main play is obvious which is to make this as enticing as...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.010(1.06%) |
Mkt cap ! $13.51M | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | $1.02 | 94.0¢ | $110.7K | 114.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15628 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1909 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |